Development and validation of a stability-indicating liquid chromatography method for the determination of dabigatran etexilate in capsules

Journal of AOAC International

Volumn 96, Issue 1, 2013, Pages 37-41

  Bernardi, Raquel M ^a   Fröehlich, Pedro E ^a   Bergold, Ana M ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMATOGRAPHIC SEPARATIONS; DEGRADATION STUDY; DIODE ARRAY DETECTORS; METHOD VALIDATIONS; MOBILE PHASE; RETENTION TIME; STABILITY-INDICATING; THERAPEUTIC EFFICACY; TRIETHYLAMINES;

ACETONITRILE; PHOSPHORIC ACID;

LIQUID CHROMATOGRAPHY;

ANTITHROMBIN; BENZIMIDAZOLE DERIVATIVE; DABIGATRAN ETEXILATE; PYRIDINE DERIVATIVE;

ARTICLE; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; METHODOLOGY; MICROCAPSULE; VALIDATION STUDY;

ANTITHROMBINS; BENZIMIDAZOLES; CAPSULES; CHROMATOGRAPHY, LIQUID; LIMIT OF DETECTION; PYRIDINES;

EID: 84874033949     PISSN: 10603271     EISSN: None     Source Type: Journal    
DOI: 10.5740/jaoacint.11-464     Document Type: Article

References (16)

1. Franchini, M., & Mannucci, P.M. (2009) Eur. J. Intern. Med. 20, 562-568. http://dx.doi.org/10.1016/j.ejim.2009.05.004.
2. Borris, L.C. (2010) Arch. Orthop. Trauma Surg. 130, 583-589. http://dx.doi.org/10.1007/s00402-009-0930-9.
3. Liesenfeld, K.H., Schäfer, H.G., Trocóniz, I.F., Tillmann, C., Eriksson, B.I., & Stangier, J. (2006) Br. J. Clin. Pharmacol. 62, 527-537. http://dx.doi.org/10.1111/j.1365-2125.2006.02667.x.
4. European Medicines Agency (2008) European Public Assessment Report. http://www.emea.europa.eu/humandocs/PDFs/EPAR/pradaxa/H-829-PI-en.pdf (accessed on July 10, 2011).
5. Ryn, J.V., Stangier, J., Haertter, S., Liesenfeld, K.H., Wienen, W., Feuring, M., & Clemens, A. (2010) Thromb. Haemost. 103, 1116-1127. http://dx.doi.org/10.1160/TH09-11-0758.
6. Eriksson, B.I., Dahl, O.E., Ahnfelt, L., Kãlebo, P., Stangier, J., Nehmiz, G., Hermansson, K., & Kohlbrenner, V. (2004) J. Thromb. Haemost. 2, 1573-1580. http://dx.doi.org/10.1111/j.1538-7836.2004.00890.x.
7. Fuji, T., Fujita, S., Ujihira, T., & Sato, T. (2010) J. Arthroplasty 25, 1267-1274. http://dx.doi.org/10.1016/j.arth.2009.08.010.
8. U.S. Food and Drug Administration (2010). http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ CardiovascularandRenalDrugsAdvisoryCommittee/UCM247244.pdf (accessed July 10, 2011).
9. Stangier, J., Rathgen, K., Stähle, H., Gansser, D., & Roth, W. (2007) Br. J. Clin. Pharmacol. 64, 292-303. http://dx.doi.org/10.1111/j.1365- 2125.2007.02899.x.
10. Stangier, J., Eriksson, B.I., Dahl, O.E., Ahnfelt, L., Nehmiz, G., Stähle, H., Rathgen, K., & Svärd, R. (2005) J. Clin. Pharmacol. 45, 555-563. http://dx.doi.org/10.1177/0091270005274550.
11. Delavenne, X., Moracchini, J., Laporte, S., Mismetti, P., & Basset, T. (2012) J. Pharm. Biomed. Anal. 58, 152-156. http://dx.doi.org/10.1016/j.jpba. 2011.09.018.
12. Beach, S., Ebner, T., Schwellinger, E.L., Stangier, J., & Roth, W. (2008) Drug. Metab. Dispos. 36, 386-399. http://dx.doi.org/10.1124/dmd.107. 019083.
13. Radtkw, G.B.E. (2011) Method for Manufacturing Medicinal Compounds Containing Dabigatran, U.S. Patent Application Publication No. 0123635 A1.
14. International Conference on Harmonization (2003) Photostability Testing of New Drugs Substance and Products Q1B, Geneva, Switzerland.
15. International Conference on Harmonization (2005) Technical Requirements for the Registration of Pharmaceutical for Human Use, Validation of Analytical Procedures: Text and Methodology Q2(R1), Geneva, Switzerland.
16. Shabir, G.A. (2003) J. Chromatogr. A 987, 57-60. http://dx.doi.org/10. 1016/S0021-9673(02)01536-4.